A genetic test result is only the start of the conversation. Genetic counselors help patients understand what their results mean and what comes next. On #GeneticCounselorAppreciationDay, we thank those who turn complex data into clear, compassionate guidance.
6
馃敩 We are LIVE at the AMP Annual Meeting & Expo in Seattle! Come find us at booth 829! Visit us to explore our OncoTarget Series, designed to provide precision genomic profiling for advanced cancer.
#AMP2026
17
Today, we honor & thank those who have served in the U.S. Armed Forces. We're proud to recognize our own, Mike Ostromecki. Thank you, Mike, for your service to our country & the dedication you bring every day. To all veterans, we extend our gratitude for your service & sacrifice.
5
Behind every diagnosis is a pathologist most patients never meet. This #InternationalPathologyDay, we recognize the professionals whose careful review of a sample can shape an entire treatment plan. Thank you to those who find the answers patients & their teams are waiting for.
14
Not every case of diabetes is type 1 or type 2. This November, during #DiabetesAwarenessMonth, we鈥檙e talking about less common forms like #MODY that often go undiagnosed. #GeneticTesting can guide accurate diagnosis & personalized treatment.
馃敆 gopathdx.com/diabetesnow
17
Advanced cancers rarely follow a single pattern, which is why detailed genomic profiling matters. Our team will be at booth 829 during the #AMP2026 Annual Meeting to talk about the OncoTarget Series & how it supports #PrecisionOncology.
1
42
We're excited to be attending the AMP Annual Meeting & Expo next month, where we'll showcase our OncoTarget Series. Visit us at booth 829 to learn more about our OncoTarget Series, molecular testing, & biopharma programs.
Learn more: gopathdx.com/amp-26
10
Counting down to the 2026 Annual LUGPA Meeting in our hometown of Chicago!
Join us as we explore genomic solutions and precision medicine in urology! Our program focuses on enhancing prostate cancer management through innovative tools and tests.
馃敆 gopathdx.com/
2
52
Not every breast cancer story begins with a lump. For some families, it starts with a pattern: a mother, an aunt, or a sister diagnosed at a young age. During #BreastCancerAwarenessMonth, we are highlighting the role hereditary risk can play & why knowing it early matters.
22
Our final #KnowYourRisk video examines MMS22L & BIK, two emerging genes still under study. Dr. Helfand explains why these findings are best considered alongside other important factors.
Thank you for following along as we help make prostate cancer a little easier to understand.
22
This installment of #KnowYourRisk covers MMS22L & BIK, two emerging genes in #prostatecancer research where the evidence is still developing. Dr. Helfand emphasizes why these results call for caution, & why neither should be treated as a stand-alone, management-changing finding.
22









